This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. In the present study, computational analysis was used to predict which miRNA might target the 3´-untranslated region (3´-UTR) of the ANXA2 mRNA. Real-time PCR and western blotting were performed to study the level of correlation between ANXA2 and the differentiation marker with the predicted miRNAs in PASMCs stimulated with serum from normal rats or those with HPS. Functional analysis of the miRNA and a luciferase reporter assay were performed to demonstrate that the predicted miRNA suppressed ANXA2 expression by directly targeting the predicted 3´-UTR site of the ANXA2 mRNA. Results: Computational analysis predicted that miR-206 would target the 3´-UTR of ANXA2 mRNA. In HPS rat serum-stimulated PASMCs, the expression of miR-206 displayed an inverse correlation with ANXA2, while a positive correlation was observed with the phenotypic marker smooth muscle α-actin (SM α-actin).
Introduction
Hepatopulmonary syndrome (HPS) is a serious complication of advanced liver disease characterised by intrapulmonary vascular dilatation (IPVD) and arterial hypoxemia. The reported incidence of HPS varies from 4% to 47% due to non-uniform diagnostic criteria, and the 2.5-year mortality rate following diagnosis with HPS reaches 41% [1] . There is currently no effective pharmacological therapy for HPS, and orthotopic liver transplantation is considered to be the only reliable treatment. The main reason for the lack of viable therapeutic measures is that the exact pathogenesis of HPS has not been identified.
Previous studies and our initial research have demonstrated that pulmonary vascular remodelling (PVR) may play an important role in the pathogenesis of HPS. In the pathogenesis of PVR, pulmonary artery smooth muscle cells (PASMCs) switch from a quiescent and contractile phenotype to a proliferative and synthetic phenotype, while endothelial cells differentiate into smooth muscle-like cells. These two features constitute the two basic pathophysiological components [2] . The identification of molecular mechanisms underlying the phenotypic modulation of PASMCs could facilitate the development of improved treatments for HPS.
Annexin A2 (ANXA2), also known as lipocortin II or p36, is a 36-kDa protein member of the annexin superfamily of calcium-dependent phospholipid-binding proteins [3] . The ability of ANXA2 to form a heterotetrameric complex plays a key role in Ca 2+ -dependent exocytosis, endocytosis and membrane organisation [4] [5] [6] . Previous studies have indicated that ANXA2 is an important regulatory protein in the process of proliferation, migration, skeletal formation and angiogenesis in a variety of malignant tumours, such as liver cancer, pancreatic cancer, breast cancer and lung cancer [7] [8] [9] . We have recently demonstrated that ANXA2 plays an important role in the process of PASMC phenotypic switching [10] . However, little is known regarding the regulation of ANXA2 gene expression. Previous work has shown that the expression of ANXA2 mRNA can be positively or negatively regulated by stimulation with Hypoxia-Inducible Factor 1 or prostaglandin E2, respectively [11, 12] . Recently, we also demonstrated that ANXA2 is regulated by serum from HPS rats. However, additional factors might be expected to restrict and tightly regulate the gene expression of ANXA2 in PASMCs.
MicroRNAs (miRNAs) are small noncoding RNAs that post-transcriptionally regulate the expression of the genes that control multiple biological processes [13] . In PASMCs, the stagespecific expression of certain miRNAs suggests their participation in PASMC phenotypic switching, which might contribute to the pathogenesis of PVR [14] . Therefore, we investigated whether some potential miRNAs implicated in PASMC phenotypic switching might regulate ANXA2 gene expression. In this study, we demonstrate that miR-206 directly downregulates ANXA2 gene expression by binding to the 3´-UTR of its mRNA, thus modulating the effects of this protein on phenotypic switching and proliferation by the PASMCs. These findings identify a role for miR-206 in the control of PASMC biology.
Materials and Methods

Reagents and antibodies
The reagents used in this study included rno-miR-206 mimics, inhibitors and negative controls, miRNA Isolation Kits, miScript II RT Kits, miScript SYBR Green PCR miRNA Detection Kits, and real-time PCR primers (Qiagen, USA); real-time RT-PCR assay kits (Takara, China); Fast-Plus EvaGreen master mix(Biotium, USA); rabbit anti-rat ANXA2 antibody, rabbit anti-rat β-actin antibody, mouse anti-rat SM α-actin antibody, HRP- A search for miRNA target genes and its binding site Three miRNA target prediction algorithms, PicTar (http://pictar.mdc-berlin.de), miRanda (http:// www.microrna.org) and TargetScan (http://www.targetscan.org), were used to identify the miRNAs possibly implicated in the regulation of ANXA2 gene expression. Subsequently, the same programs were used to identify the potential miRNA target genes. The miRanda algorithm was used to predict the putative miRNA binding sites.
Cell culture
The rat PASMCs were isolated from rat pulmonary arteries as previously described [10] . Briefly, healthy Sprague-Dawley rats were killed by exsanguination under pentothal anaesthesia. After the adventitia and endothelia were removed, the pulmonary artery was cut into small pieces and then cultured using the tissue-sticking method [15] . The purity and identity of the PASMCs was verified by typical morphological patterns and immunocytochemical staining using specific monoclonal antibodies raised against SM α-actin, as previously reported [16, 17] . The PASMCs were used for experiments between passages 5 and 9. Cultures of PASMCs at a density of 10 6 /cm 2 were divided into two groups: the control group, consisting of PASMCs that were cultured in DMEM supplemented with 5% normal rat serum,and the HPS group, consisting of PASMCs that were incubated in DMEM containing 5% serum from the HPS ratsfor various time periods (24 h, 48 h and 72 h).
HPS rat model
All procedures performed on the rats were conducted according to the guidelines from the National Institutes of Health. The study's protocol was approved by the Committee on Animal Research of Southwest Hospital. The HPS rat model was established as described in our previous study [18] . Briefly, HPS was induced in Sprague-Dawley rats (180-220 g) by common bile duct ligation (CBDL). HPS rat serum was obtained from the CBDL rats that met the following criteria: 1) gas exchange abnormalities (PaO2<85 mmHg and P(A-a)O2>18 mmHg) and 2) intrapulmonary vascular dilation, confirmed by histopathological analysis. Normal rat serum was obtained from the rats in the sham-operated control group. All of the serum samples were stored at −80°C for use in the subsequent experiments.
Transfection
After growth arrest, PASMCs were transfected with different groups of oligo nucleotides. The transfection complexes were prepared according to the manufacturer's instructions. For the overexpression of miR-206, an miR-206 mimic(10 nmol/L) was added to the complexes. Alternatively, an miR-206 inhibitor (200 nmol/L) was added to the complexes to induce knockdownof miR-206. The overexpression of ANXA2 was achieved by transient transfection using an ANXA2-expressing plasmid. The controls consisted of the application of oligo controls for the miR-206 mimic or miR-206 inhibitor, or an empty plasmid. At 24 h prior to treatment, miR-206, ANXA2 or both were transfected into the PASMCs using the Lipofectamine2000 reagent. The efficiency of transfection was confirmed using real-time PCR and western blotting.
Western blotting
The cultured cells were lysed and subjected to total protein extraction, according to the manufacturer's instructions. After the protein concentrations were determined using the BCA protein assay, equal quantities of protein were analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred onto the PVDF membranes. The membranes were blocked for 1 h using the blocking solution and then incubated overnight with the primary antibody (1:1000 dilution) at 4°C. After washing three times with Tris-Buffered Saline Tween-20 (TBST), the membrane was incubated with HRP-conjugated rabbit anti-goat IgG at a 1:1000 dilution for 1 h at room temperature before being washed again in TBST and visualised with an enhanced chemiluminescence reagent. Finally, the immunoreactive bands were scanned and stored using a gel imaging system. The intensity of the immunoreactivity was measured and analysed with an Alpha Imager.
Real-time PCR
Total RNA was extracted using the miRNeasy isolation kit. For the measurement of ANXA2 mRNA expression, the RNA (1µg) was reverse-transcribed using the real-time PCR assay kits, followed by realtime PCR using the Fast-Plus EvaGreen master mix. For the miRNA expression analysis, the RNA (2µg) was reverse-transcribed using the miScript II RT Kit, followed by real time PCR using the miScript SYBR Green PCR miRNA Detection Kit. The amplification and detection of the specific products were performed using the iCycleriQ Real-Time PCR Detection System. U6 was used as an internal control for the miRNA template normalisation, and glyceraldehyde 3-phosphate dehydrogenase (GADPH) was used for the other template normalisations. The PCR primers for ANXA2 were as follows: forward, 5'-TGAGCGGGATGCTTTGAAC-3', and reverse, 5'-ATCCTGTCTC TGTGCATTGCTG-3'.The GADPH PCR primers were as follows: forward, 5'-GGCACAGTCAAGGCTGAGAATG-3', and reverse, 5'-ATGGTGGTGAAGACGCCAGTA -3'.
Immunofluorescence
For immunofluorescence, the PASMCs were fixed with 4% paraformaldehyde and permeabilised with 0.2% Triton X-100. After blocking with 1% goat serum, the PASMCs were incubated with a 1:100 dilution of the ANXA2 antibody and a 1:100 dilution of the SM α-actin antibody at 4°Covernight. Following washing, the sections were incubated with Alexa Fluor 488 goat anti-mouse IgG antibody and Alexa Fluor 555 rabbit anti-goat IgG antibodies for 2 h at room temperature. The nuclear DNA was stained with DAPI. The images were then captured using a Leica DM 3000 microscope and photographed using a DFC420 camera.
Luciferase assay HEK 293 cells were co-transfected with the constitutively active Renillareniformis luciferaseproducing vector pRL, the hsa-miR-206 or a non-targeting pre-miR-negative control and the luciferase wild-type or mutated 3´-UTR vectors for ANXA2 using the SiportNeoFX transfection reagent according to the manufacturer's instructions. At 20 hours after the transfection, the cells were lysed, and the relative luciferase expression was measured on a scintillation counter with a dual luciferase reporter system.
Thymidine incorporation assay
Equal numbers of PASMCs were seeded into the wells of a 96-well plate in complete medium. After 24 h of synchronous growth, the cells were transfected with the miR-206 mimic, ANXA2 or both according to the manufacturer's instructions. Next, the cells were incubated with DMEM containing the different sera for the indicated periods, and the medium was supplemented with 1µCi 3 H-TdR during the last 6 h of the treatment period. The incorporation was stopped with cold PBS solution, and 0.25% trypsin was added to separate the cells from the cell wall. The cells were collected onto a glass fibre filter with a multi-head harvester. Then, the cells were washed 3 times with physiological saline, stabilised with 10% trichloroacetic acid, decolourised with absolute ethanol, dried for 30 min at 80°C, transferred into scintillation fluid and counted with a liquid scintillation counter (counts/min, cpm).
CCK-8 assay
The cellular proliferation was measuredby the Cell Counting Kit-8 (CCK-8) assay. Accordingly, 24 h after seeding equal numbers of PASMCs, the cells were transfected with the miR-206 mimic, ANXA2 or both. After transfection, the cells were incubated with DMEM containing the different sera for the indicated time periods. At the end of treatment, 10µl of the CCK-8 solution was added to each well, and cells were cultured for 2 h. After that, the numbers of viable cells were quantified by measuring the absorbance value at 450 nm using a microplate absorbance reader.
Statistical analysis
All data are expressed as the mean±SEM. The comparisons between groups were carried out using Student's t-test or a Mann-Whitney U-test for parametric or non-parametric data, respectively. The results were considered to be statistically significant when p < 0.05.
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Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry levels of miR-206 with ANXA2 and the differentiation marker protein, SM α-actin, in the PASMCs. The PASMCs were treated with 5% HPS rat serum or normal rat serum for different time periods: 0 h, 24 h, 48 h and 72 h. The expression levels of miR-206, ANXA2 and SM -actin were measured at each of these time points. Western blotting showed that the expression levels of the PASMC differentiation marker SM α-actin were downregulated, while the expression levels of ANXA2 protein were upregulated in a time-dependent manner in the HPS serum-treated group (Fig. 1A) . However, there was no significant change in group C (Fig. 1B) . Real-time PCR demonstrated that the pattern of the expression levels of ANXA2 mRNA was similar to that of the protein levels ( Fig. 1C and D) , whereas the levels of miR-206 showed the opposite expression pattern (Fig. 1E and F) . These results indicate that miR-206 may play a role in the phenotypic modulation of the PASMCS by negatively regulating ANXA2 gene expression. protein levels of ANXA2 were downregulated by the miR-206 mimic, whereas they were upregulated by the miR-206 inhibitor ( Fig. 3A and B) . To further confirm that the effect of miR-206 on ANXA2 gene expression was direct and that it was due to the binding of miR-206 to the 3´-UTR of the ANXA2 mRNA, we inserted the ANXA2 3´-UTR region, which contains the predicted miR-206 recognition site (ACAUUCC), into a luciferase reporter plasmid. By cotransfecting the miR-206 mimic and the luciferase vector with the ANXA2 3´-UTR into HEK 293 cells, we demonstrated that the miR-206 mimic significantly repressed the luciferase activity of wild type reporter. This effect was not observed in the analogous mutated reporter in which the sequence of "ACAUUCC" had been replaced with "AACGGAA" to prevent the binding of miR-206 to the ANXA2 3´-UTR region ( Fig. 3C and D) . These results suggest that miR-206 affects ANXA2 gene expression by directly binding to the complementary 3´-UTR region of the ANXA2 mRNA.
ANXA2 mediates the effects of miR-206 on the phenotypic modulation and proliferation of PASMCs
To determine the relative role of ANXA2 in mediating the effects of miR-206 on the phenotypic modulation of PASMCs induced by HPS rat serum, we overexpressed ANXA2 in cultured PASMCs using a transient transfection of the ANXA2-expressing plasmid. Western blotting demonstrated that the expression level of ANXA2 protein was significantly increased at 48 h after the transient transfection, compared with the vehicle and empty plasmid controls (Fig. 4A) . Next, the PASMCs were transfected with the miR-206 mimic (10 nM), the ANXA2-expressing plasmid or both and were stimulated with HPS rat serum for 48 h. The expression levels of SM α-actin were measured. Our data showed that the miR-206 mimic, (Fig. 5A and B) .
Taken together, these results suggest that ANXA2 is a functional target gene of miR-206 and that it is involved in the HPS rat serum-induced phenotypic modulation and proliferation of PASMCs.
Discussion
Due to the stimulation of circulating cytokines and hypoxia, liver cirrhosis and portal hypertension can induce the phenotypic modulation of PASMCs, resulting in PVR. Previous studies of the molecular events underlying PVR have already investigated the signalling pathways, including MLCK, JAK/STAT, PI3K/Akt, and PKC/MAPK, that can regulate the proliferation and migration of PASMCs [19] [20] [21] . However, due to the redundant functions among these signalling pathways, the inhibition of a single pathway is usually not effective in preventing the processes that result in PVR. Thus, targeting the upstream events may be a more effective approach to blocking this process. Accumulating evidence has indicated that inhibiting the phenotypic modulation of PASMCs is a key upstream regulatory target because contractile PASMCs cannot proliferate and migrate [22] . Therefore, controlling the phenotypic modulation of PASMCs has become a feasible approach to efficiently prevent PVR and treat pulmonary proliferative vascular diseases. 
Cellular Physiology and Biochemistry
ANXA2, which is widely expressed in many tissues and cells including PASMCs, is involved in the regulation of many biological processes, including cell differentiation, proliferation and migration. Specifically, ANXA2 has been shown to participate in the modulation of multiple signal transduction pathways, including p53 signalling, calcium/cAMP/lipid signalling, and focal adhesion signalling [3, 23, 24] . We previously reported that the expression levels of ANXA2 were increased in both the HPS pulmonary artery wall and PASMCs incubated with HPS rat serum, compared with the levels in the control group. Furthermore, the modulation of the ANXA2 gene expression in HPS rat serum-treated PASMCs significantly affects the phenotype and proliferation of the PASMCs. In contrast, the phenotype and proliferation of PASMCs cultured in normal rat serum were not obviously changed [10] .
miR-206, a member of the highly conserved miR-206 family, is a functional miRNA in both physiological and pathological conditions. As one of the differentiation-related miRNAs, miR-206 has been demonstrated to play a crucial role in the process of cellular differentiation. Dey et al. [25] showed that the differentiation and proliferation of myoblasts were modulated by miR-206 through its direct target, pax7. Inose et al. [26] identified miR-206 as a key regulator of osteoblast differentiation, where it acts by inhibiting the expression of the connexin 43 gene. Jalali et al. [27] confirmed that miR-206 is a potential regulator of proliferation and differentiation of PASMCs in pulmonary arterial hypertension. As an anti-oncogenic miRNA, miR-206 has been shown to inhibit both tumourigenesis and tumour progression. Song et al. [28] determined that miR-206 is a pro-apoptotic activator of cell death that is associated with the regulation of Notch3 function and thus the suppression of tumour growth. Wang et al. [29] found that a low level of miR-206 expression is significantly correlated with the metastatic potential of lung cancer. All these studies indicate that miR-206 plays a critical role in cell differentiation and proliferation.
In the present study, we first applied the computational analysis to predict the potential miRNAs that target the 3´-UTR of ANXA2 mRNA, and we identified miR-206 as the most likely regulator. Next, the inverse correlation between miR-206 and ANXA2 and the positive correlation between miR-206 and SM α-actin were confirmed in cultured PASMCs treated with HPS rat serum or normal rat serum. Based on this observation, we confirmed that miR-206 downregulates ANXA2 and up-regulates SM α-actin gene expression through gain-offunction and loss-of-function approaches. Consistent with the decrease in the expression of ANXA2 induced by miR-206, the ability of miR-206 to bind to the 3´-UTR of ANXA2 mRNA was validated using a dual luciferase reporter gene assay. Finally, we confirmed that the phenotypic modulation of PAMSCs mediated by ANXA2 is regulated by the HPS rat seruminduced inhibition of miR-206 expression.
Taken together, our study for the first time revealed that miR-206 acts as a novel regulator of the PASMC phenotype via its target gene ANXA2. The decreased miR-206 levels increased the expression of ANXA2, while increases in the expression of ANXA2 suppressed the PASMC phenotype marker gene, possibly via downstream molecules such as ERK1/2, NF-kB and β-catenin [30, 31] . The dedifferentiated PASMCs demonstrated increased proliferation rates, resulting in PVR [32] . Although our current study was limited by a lack of animal and human tissue experiments, the findings may still have a significant impact on our understanding of HPS-associated PVR.
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